His main research concerns Parkinson's disease, Internal medicine, Disease, Restless legs syndrome and Physical therapy. His Parkinson's disease study integrates concerns from other disciplines, such as Psychiatry, Central nervous system disease and Parkinsonism. His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Surgery.
As part of the same scientific family, he usually focuses on Disease, concentrating on Pediatrics and intersecting with Ambulatory care. His Restless legs syndrome research is multidisciplinary, incorporating perspectives in Anesthesia, BTBD9, Rotigotine and Neurological disorder. His work carried out in the field of Physical therapy brings together such families of science as Rating scale, Randomized controlled trial, Quality of life, Prospective cohort study and Severity of illness.
His primary areas of study are Parkinson's disease, Internal medicine, Disease, Neuroscience and Anesthesia. The Parkinson's disease study combines topics in areas such as Physical therapy, Psychiatry, Central nervous system disease and Parkinsonism. Wolfgang H. Oertel combines subjects such as Neurology, Quality of life and Rating scale with his study of Physical therapy.
His work in Internal medicine addresses subjects such as Surgery, which are connected to disciplines such as Pediatrics. The concepts of his Anesthesia study are interwoven with issues in Tolerability, Adverse effect, Levodopa, Placebo and Restless legs syndrome. His research integrates issues of Rotigotine and Neurological disorder in his study of Restless legs syndrome.
Wolfgang H. Oertel mostly deals with Parkinson's disease, Internal medicine, Disease, REM sleep behavior disorder and Neuroscience. Parkinson's disease is a subfield of Pathology that Wolfgang H. Oertel investigates. His research in Internal medicine intersects with topics in Gastroenterology and Endocrinology.
His studies in Disease integrate themes in fields like Genetics, Physical therapy, Physical medicine and rehabilitation and Intensive care medicine. His REM sleep behavior disorder research incorporates elements of Prodromal Stage, Cohort study, Cohort and Synucleinopathies. His Alpha-synuclein study which covers Pharmacology that intersects with MPTP.
Wolfgang H. Oertel spends much of his time researching Parkinson's disease, Internal medicine, Disease, Parkinsonism and Neuroscience. His Parkinson's disease study necessitates a more in-depth grasp of Pathology. His study in Internal medicine is interdisciplinary in nature, drawing from both Neurology and Depression.
The various areas that Wolfgang H. Oertel examines in his Disease study include Rapid eye movement sleep, Prospective cohort study, Physical therapy, Pediatrics and Prodrome. Wolfgang H. Oertel studied Parkinsonism and Severity of illness that intersect with Blood pressure, Heart rate, Confidence interval and Polysomnography. His Neuroscience research includes themes of Endocrinology and Anatomy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Günther Deuschl;Carmen Schade-Brittinger;Paul Krack;Jens Volkmann.
The New England Journal of Medicine (2006)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome
Jun Horiguchi;Magdolna Hornyak;Ulrich Voderholzer;Meir Kryger.
Sleep Medicine (2003)
Toward a better definition of the restless legs syndrome
Arthur S. Walters;Michael S. Aldrich;Richard Allen;Sonia Ancoli‐Israel.
Movement Disorders (1995)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Alexander Gerhard;Nicola Pavese;Gary Hotton;Federico Turkheimer.
Neurobiology of Disease (2006)
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
H. Sauer;W.H. Oertel.
Neurostimulation for Parkinson's Disease with Early Motor Complications
W. M. M. Schuepbach;J. Rau;K. Knudsen;J. Volkmann.
The New England Journal of Medicine (2013)
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
Günter U Höglinger;Pamela Rizk;Marie P Muriel;Charles Duyckaerts.
Nature Neuroscience (2004)
MDS research criteria for prodromal Parkinson's disease
Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem.
Movement Disorders (2015)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol;DJ Brooks;E Melamed;W Oertel.
The Lancet (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: